EGFR-IN-134
Product Specifications
UNSPSC Description
EGFR-IN-134 (compound 3f), a triazolo[3,4-a]isoquinoline derivative, is a potent EGFR inhibitor with an IC50 of 0.023 µM. EGFR-IN-134 induces apoptosis and necrosis. EGFR-IN-134 initiates cell cycle arrest at the G2/M and pre-G1 phases, downregulates anti-apoptotic protein Bcl2 and upregulates pro-apoptotic proteins: p53, Bax, and caspases 3, 8, and 9. EGFR-IN-134 shows antiproliferative and anticancer activity[1].
Target Antigen
Apoptosis; Bcl-2 Family; Caspase; EGFR; MDM-2/p53; Necroptosis
Type
Reference compound
Related Pathways
Apoptosis;JAK/STAT Signaling;Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/egfr-in-134.html
Smiles
O=C(C1=NN(C2=CC=C([N+]([O-])=O)C=C2)C3N1CCC4=C3C=C(OC)C(OC)=C4)/C=C/C5=CN(C6=CC=CC=C6)N=C5C7=CC=CC=C7
Molecular Weight
626.66
References & Citations
[1]Nesma Abdelaal, et al. Design, in silico studies and biological evaluation of novel chalcones tethered triazolo[3,4-a]isoquinoline as EGFR inhibitors targeting resistance in non-small cell lung cancer. Sci Rep. 2024 Nov 4;14(1):26647.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-168623/EGFR-IN-134-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-168623/
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![3'-Hydroxy-[1,1'-biphenyl]-2-carboxylic acid](https://cdn.genprice.uk/genprice/genprice2.png)
![3'-Hydroxy-[1,1'-biphenyl]-2-carboxylic acid](https://cdn.genprice.uk/genprice/genprice5.png)